Paediatric antidepressants: Benefits and risks.

Paediatric antidepressants: Benefits and risks.
Int J Risk Saf Med. 2018 May 25;:
Authors: Healy D, Le Noury J, Jureidini J
Abstract
The data supporting the use of "antidepressants" in children and adolescents is largely unavailable. Academic publications give a different picture as regards benefits and harms to publications from regulatory other sources. Despite disagreements about the data driving use of these medicines, in practice "antidepressants" may now be the most commonly used drugs by adolescent girls, and children's mental health services are attracting increasing attention.This paper reviews the difficulties surrounding the data. It outlines a case for benefits (as well as risks) that would require physicians to exert a greater degree of professional autonomy than service managers might wish.
PMID: 29865094 [PubMed - as supplied by publisher]

Source: International Journal of Risk and Safety in Medicine - June 6, 2018 Category: Drugs & Pharmacology Tags: Int J Risk Saf Med Source Type: research